Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Wen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Gene Therapy|August 27, 2011
SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancerS-P Hsueh, W-B Hsu, C-C Wen, et al.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|March 4, 2021
[Spatial and temporal characteristics of reported schistosomiasis cases in China based on a Bayesian interrupted time-series model]C C Wen, T T Zhao, W H Hu, et al.
The Journal of Pharmacy and Pharmacology|March 13, 2003
Profound difference in pharmacokinetics between morin and its isomer quercetin in ratsY C Hou, P D L Chao, H J Ho, et al.
Clinical Pharmacology and Therapeutics|October 23, 2012
The UCSF-FDA TransPortal: a public drug transporter databaseK M Morrissey, C C Wen, S J Johns, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug responseC C Wen, S W Yee, X Liang, et al.
Clinical Pharmacology and Therapeutics|March 4, 2011
Functional characterization of liver enhancers that regulate drug-associated transportersM J Kim, P Skewes-Cox, H Fukushima, et al.
Molecular Psychiatry|September 9, 2015
A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samplesO S Cohen, T W Weickert, J L Hess, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Gene Therapy|August 27, 2011
SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancerS-P Hsueh, W-B Hsu, C-C Wen, et al.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|March 4, 2021
[Spatial and temporal characteristics of reported schistosomiasis cases in China based on a Bayesian interrupted time-series model]C C Wen, T T Zhao, W H Hu, et al.
The Journal of Pharmacy and Pharmacology|March 13, 2003
Profound difference in pharmacokinetics between morin and its isomer quercetin in ratsY C Hou, P D L Chao, H J Ho, et al.
Clinical Pharmacology and Therapeutics|October 23, 2012
The UCSF-FDA TransPortal: a public drug transporter databaseK M Morrissey, C C Wen, S J Johns, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug responseC C Wen, S W Yee, X Liang, et al.
Clinical Pharmacology and Therapeutics|March 4, 2011
Functional characterization of liver enhancers that regulate drug-associated transportersM J Kim, P Skewes-Cox, H Fukushima, et al.
Molecular Psychiatry|September 9, 2015
A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samplesO S Cohen, T W Weickert, J L Hess, et al.
Pageof 1